UNITED STATES

             SECURITIES AND EXCHANGE COMMISSION

                   Washington, D.C. 20549


                          FORM 8-K
                       CURRENT REPORT

   Pursuant to Section 13 or 15(d) of the Securities and
                    Exchange Act of 1934


    Date of Report (Date of Earliest Event Reported):
                June 23, 2004 (June 15, 2004)

                     INNOVO GROUP INC.
   (Exact name of registrant as specified in charter)

     Delaware          0-18926              11-2928178
(State or other (Commission File No.)     (IRS Employer
  jurisdiction                         Identification No.)
of incorporation)

5804 East Slauson Avenue,  Commerce, California    90040
   (Address of principal executive offices)     (Zip Code)

    Registrant's telephone number, including area code:
                      (323) 725-5516

                         No Change
(Former name or former address, if changed since last filing)

                          

Item 5.  Other Events and Required FD Disclosure

Financing Transactions

      On June 15, 2004, June 18, 2004 and June 22, 2004,  we
executed  agreements for the sale of convertible  promissory
notes  and common stock purchase warrants which resulted  in
aggregate  gross proceeds to us of $2.5 million  immediately
and an additional $451,875 in aggregate gross proceeds to us
upon  exercise of the warrants.  The convertible  promissory
notes  in  the  aggregate principal amount of $2.5  million,
together with common stock purchase warrants to purchase  an
aggregate of 312,500 shares of our common stock were sold to
three  "accredited investors," as defined  in  Regulation  D
promulgated under the Securities Act of 1933, as amended, or
the Securities Act.  The transaction documents executed with
each  purchaser were substantially similar and are  attached
hereto and incorporated herein as Exhibits 4.1, 4.2 and 4.3,
respectively.

       The   convertible  promissory  note  issued  to  each
purchaser bears interest at a rate of 7.5% per annum and has
a  maturity  date twelve months from the date  of  issuance.
The  convertible note is convertible at any  time  from  the
date  of issuance into shares of our common stock at a price
per  share equal to 110% of the average of the closing price
of  our  common stock for the five trading days  immediately
prior  to  the  date of issuance, which for  each  purchaser
results  in  a conversion price of $1.53, $1.41  and  $1.35,
respectively.  We will pay interest only payments until  the
maturity  date  of  the  convertible  note,  unless  it   is
converted  or  prepaid.   We have  an  option  to  make  one
prepayment of the note, in whole or in part, without penalty
at  any time after three months.  However, in the event that
we  elect to prepay the convertible note, the purchaser  may
elect  within 3 days to convert the note in accordance  with
its terms.

      Each  purchaser was also issued corresponding warrants
to  purchase shares of common stock.  The number  of  shares
that the purchaser will be eligible to purchase is equal  to
12.5%  of the aggregate amount of the convertible promissory
note  and the exercise price of the warrants on a per  share
basis  is equal to 110% of the average of the closing  price
of  our  common stock for the five trading days  immediately
prior to the date of issuance of the warrant, which for each
purchaser  results in an exercise price of $1.53, $1.41  and
$1.35,  respectively.  The warrants expire five  years  from
the  date  of issuance and are exercisable immediately.   In
connection with both the convertible notes and the warrants,
we entered into a registration rights agreement with each of
the purchasers.

      Each  purchaser represented to Innovo Group that  they
are  an  "Accredited Investor," as that term is  defined  in
Rule  501(a) of Regulation D under the Securities Act.   The
convertible notes and warrants were offered and sold to each
purchaser  in  reliance upon an exemption from  registration
under Rule 506 of Regulation D the Securities Act.


                          

Item 7.  Exhibits


(c)  Exhibits

     Exhibit
     Number    Description

     Exhibit 4.1    Form of Convertible Promissory Note

     Exhibit 4.2    Form of Common Stock Purchase Warrant

     Exhibit 4.3    Form of Registration Rights Agreement


                          


                         SIGNATURES


     Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has  duly caused this  report to
be signed on  its behalf  by the  undersigned thereunto duly
authorized.


                           INNOVO GROUP INC.
                           (Registrant)

Date:  June 23, 2004       By: /s/ Samuel J. Furrow, Jr.
                              --------------------------
                              Samuel J. Furrow, Jr.
                              Chief Executive Officer and Director
                              (Principal Executive Officer